Haarman & Reimer Eyes Improved Market Position Through Pending Sale
This article was originally published in The Rose Sheet
Executive Summary
Bayer Corp. aims to divest fragrance and flavor manufacturer Haarman & Reimer by the end of 2002, the German company announced Dec. 6
You may also be interested in...
H&R sale anticipated by summer
"Binding offers" for Bayer's Haarman & Reimer fragrance and flavors business expected by May, Chairman of the Board of Management Manfred Schneider, PhD, says during Bayer's 1March 13 spring financial presentation. German firm expects to complete sale by summer, Schneider adds. H&R 2002 sales are projected at $763 mil. (E1= $.88), according to Bayer. Among companies expected to make a bid for H&R are Swiss fragrance supplier Givaudan and German specialty chemicals business Degussa. Bayer announced plans to divest division late last year as part of firm's restructuring effort (2"The Rose Sheet" Dec. 10, 2001, p. 6)...
H&R sale anticipated by summer
"Binding offers" for Bayer's Haarman & Reimer fragrance and flavors business expected by May, Chairman of the Board of Management Manfred Schneider, PhD, says during Bayer's 1March 13 spring financial presentation. German firm expects to complete sale by summer, Schneider adds. H&R 2002 sales are projected at $763 mil. (E1= $.88), according to Bayer. Among companies expected to make a bid for H&R are Swiss fragrance supplier Givaudan and German specialty chemicals business Degussa. Bayer announced plans to divest division late last year as part of firm's restructuring effort (2"The Rose Sheet" Dec. 10, 2001, p. 6)...
Bayer moves closer to H&R sale
Fragrance and flavors supply business Haarmann & Reimer is expected to sell above current market expectations of $1.33 bil. (€1=$.88), Bayer says. Many competitors in the chemical industry have expressed interest in acquiring the division, Bayer adds. Among companies reportedly planning to bid for H&R are Swiss fragrance supplier Givaudan and German chemicals business Degussa. Although neither company would confirm their intentions, both say they are interested in future acquisitions. Bayer announced plans to sell Haarmann & Reimer in December as one of three divisions the company is shedding to focus on "core" businesses (11"The Rose Sheet" Dec. 10, 2001, p. 6)...